August 2016, Agendia in New England Journal - Korys

about us / press releases

New England Journal of Medicine Publishes MINDACT Trial Results Proving the Clinical Utility of MammaPrint

http://www.agendia.com/new-england-journal-of-medicine-publishes-mindact-trial-results/

Share this article

Overview

Mablink announces €31 million funding round

First Farmer-led Company in India raises Capital from Group of European Investors

Korys and Ingrizo join forces for even more sustainable, functional ingredients and solutions for food and health applications

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

Trunkrs raises EUR15 million in growth capital from Korys, VP Capital and SET Ventures

CAIRDAC raises €17m to finance the development of ALPS the first SELF-SUSTAINABLE LEADLESS PACEMAKER

Fluves announces the investment of Virya Energy, resulting in a significant minority share in Fluves and its daughter company Marlinks

Hyoffwind partners with John Cockerill and BESIX to build a green hydrogen production facility in Zeebrugge

Colruyt Group acquires stake in SMARTMAT NV and strengthens its market leadership in Belgian food e-commerce

Climate scale-up Sensorfact raises 13 million euros to make industry more sustainable

V-Bio Ventures raises additional capital to support young biotech companies

New online supermarket focuses on service and experience

Belgian impact fund backs the entrepreneurial spirit on the Indian countryside

Korys joins Dutch bike manufacturer Santos Bikes

MRM Health Receives CTA Approval for Phase 1b/2a Trial with Next Generation Optimized Consortium Therapeutic MH002 in Ulcerative Colitis